Letairis (Ambrisentan) - Current Clinical Trials

Letairis Related Clinical Trials

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension [Recruiting]

Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan [Recruiting]

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis [Recruiting]

Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor (PDE-5i) to Treat Pulmonary Arterial Hypertension [Recruiting]

(ARTEMIS-IPF)Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF [Recruiting]

Pharmacogenomics in Pulmonary Arterial Hypertension [Recruiting]

An Observational Study For Ambrisentan [Recruiting]

A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma). [Recruiting]

A Study to Evaluate GSK1325760A - a Long-Term Extension Study [Recruiting]

Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension [Recruiting]